Roivant Sciences Ltd. Executive Sells Over 400K Shares
| Reporter Name | Sukhatme Mayukh |
| Relationship | Pres&Chief Investment Officer |
| Type | Sell |
| Amount | $4,971,637 |
| SEC Filing | Form 4 |
Mayukh Sukhatme, serving as President and Chief Investment Officer at Roivant Sciences Ltd., and holding a director position, sold 412,584 Common Shares on December 18, 2024. The sale was executed at a weighted average price of $12.05 per share, totaling approximately $4,971,637. Following this transaction, Sukhatme directly owns 18,836,547 Common Shares of the company.
SEC Filing: Roivant Sciences Ltd. [ ROIV ] - Form 4 - Dec. 20, 2024